88709-63-1 Usage
Molecular structure
1H-Pyrrole-3-carbonitrile,2-[[2-(diethylamino)ethyl]thio]-4-[4-(dimethylamino)phenyl]-4,5-dihydro-5-oxo-4-(3-pyridinyl)is a complex molecule that contains a pyrrole ring with a carbonitrile group (CN) attached, as well as various functional groups such as an ethylthio group (-SCH2CH3), a dimethylamino group (-N(CH3)2), and a pyridinyl group (containing a six-membered nitrogen-containing ring).
Chemical classification
1H-Pyrrole-3-carbonitrile,2-[[2-(diethylamino)ethyl]thio]-4-[4-(dimethylamino)phenyl]-4,5-dihydro-5-oxo-4-(3-pyridinyl)- is an organic compound, specifically a nitrogen-containing heterocyclic compound, due to the presence of pyrrole, pyridine, and other nitrogen-containing functional groups.
Physical state
As a complex organic molecule, it is likely to be a solid at room temperature and pressure.
Polarity
The presence of multiple polar functional groups, such as the carbonitrile group, ethylthio group, and dimethylamino group, suggests that the molecule is likely to be polar.
Solubility
Due to its polar nature and the presence of various functional groups, 1H-Pyrrole-3-carbonitrile,2-[[2-(diethylamino)ethyl]thio]-4-[4-(dimethylamino)phenyl]-4,5-dihydro-5-oxo-4-(3-pyridinyl)- may be soluble in polar solvents such as water, alcohols, or dimethyl sulfoxide (DMSO), but its exact solubility profile would depend on the specific interactions between the functional groups and the solvent.
Reactivity
The compound's reactivity would depend on the specific interactions and reactivity of each functional group within the molecule. For example, the carbonitrile group may undergo nucleophilic addition reactions, while the pyridinyl group may participate in electrophilic aromatic substitution reactions.
Potential applications
Due to its unique and intricate structure, 1H-Pyrrole-3-carbonitrile,2-[[2-(diethylamino)ethyl]thio]-4-[4-(dimethylamino)phenyl]-4,5-dihydro-5-oxo-4-(3-pyridinyl)- may be useful in a range of applications such as pharmaceuticals (e.g., as a drug candidate or intermediate in drug synthesis), organic synthesis (e.g., as a building block or reagent in the synthesis of other complex molecules), and material science (e.g., as a component in the development of new materials with specific properties).
Stability
The stability of 1H-Pyrrole-3-carbonitrile,2-[[2-(diethylamino)ethyl]thio]-4-[4-(dimethylamino)phenyl]-4,5-dihydro-5-oxo-4-(3-pyridinyl)- would depend on factors such as its molecular structure, the presence of any labile functional groups, and the conditions under which it is stored or used (e.g., temperature, pressure, exposure to light or moisture).
Check Digit Verification of cas no
The CAS Registry Mumber 88709-63-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,8,7,0 and 9 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 88709-63:
(7*8)+(6*8)+(5*7)+(4*0)+(3*9)+(2*6)+(1*3)=181
181 % 10 = 1
So 88709-63-1 is a valid CAS Registry Number.
88709-63-1Relevant academic research and scientific papers
2-Pyrrolin-3-carbonitrile derivatives, and pharmaceutical compositions containing them and their anti-inflammatory and ulcer protective activity
-
, (2008/06/13)
The present invention provides compounds of the general formula I STR1 wherein R1 and R2, which are the same or different, are unsubstituted or substituted aromatic rings, Alk is a straight-chained or branched lower hydrocarbon chain and Z is a hydrogen atom, with the proviso that when Alk is a straight-chained hydrocarbon chain, Z can also be a lower alkylamino radical of the general formula II STR2 in which R3 and R4 are the same or different and are hydrogen atoms or straight-chained or branched lower alkyl radicals or R3 and R4, together with the nitrogen atom to which they are attached, can also form a ring optionally containing further hetero atoms; and the pharmacologically acceptable salts thereof. The present invention also provides an inventive process for preparing these compounds, as well as pharmaceutical compositions containing them. The compounds I may be used in the therapy of inflammations and they are free of gastrointestinal side effects.
